Detalhe da pesquisa
1.
Preclinical Characterization of Relatlimab, a Human LAG-3-Blocking Antibody, Alone or in Combination with Nivolumab.
Cancer Immunol Res
; 10(10): 1175-1189, 2022 10 04.
Artigo
Inglês
| MEDLINE | ID: mdl-35981087
2.
Improved therapeutic index of an acidic pH-selective antibody.
MAbs
; 14(1): 2024642, 2022.
Artigo
Inglês
| MEDLINE | ID: mdl-35192429
3.
An Integrative Approach to Inform Optimal Administration of OX40 Agonist Antibodies in Patients with Advanced Solid Tumors.
Clin Cancer Res
; 25(22): 6709-6720, 2019 11 15.
Artigo
Inglês
| MEDLINE | ID: mdl-31573956
4.
Elective Nodal Irradiation Attenuates the Combinatorial Efficacy of Stereotactic Radiation Therapy and Immunotherapy.
Clin Cancer Res
; 24(20): 5058-5071, 2018 10 15.
Artigo
Inglês
| MEDLINE | ID: mdl-29898992
5.
Correction: Preclinical Development of Ipilimumab and Nivolumab Combination Immunotherapy: Mouse Tumor Models, In Vitro Functional Studies, and Cynomolgus Macaque Toxicology.
PLoS One
; 11(11): e0167251, 2016.
Artigo
Inglês
| MEDLINE | ID: mdl-27861630
6.
Preclinical Development of Ipilimumab and Nivolumab Combination Immunotherapy: Mouse Tumor Models, In Vitro Functional Studies, and Cynomolgus Macaque Toxicology.
PLoS One
; 11(9): e0161779, 2016.
Artigo
Inglês
| MEDLINE | ID: mdl-27610613
7.
In vitro characterization of the anti-PD-1 antibody nivolumab, BMS-936558, and in vivo toxicology in non-human primates.
Cancer Immunol Res
; 2(9): 846-56, 2014 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-24872026
8.
An alphavirus replicon particle chimera derived from venezuelan equine encephalitis and sindbis viruses is a potent gene-based vaccine delivery vector.
J Virol
; 77(19): 10394-403, 2003 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-12970424